Does your leadership style foster innovation? How would you answer? Gain insights from this panel of top leaders and presenters.
Moderator: Linda McHugh, Chief Human Resources Officer, Cleveland Clinic
Andre Machado, MD, PhD, Chair, Neurological Institute, Cleveland Clinic
Margaret McKenzie, MD, President, South Pointe Hospital
Kristen Morris, Chief Government Relations Officer, Cleveland Clinic
Andrea Sikon, MD, Chair, Internal Medicine and Geriatrics, Cleveland Clinic
Cleveland Clinic’s Top 10 list of breakthrough technologies for the coming year has become an international sensation. Join us again as Dr. Mike Roizen and a panel of ten Clinic leaders roll out these much-anticipated selections.
Moderator: Michael Roizen, MD, Chief Wellness Officer
Daniel Cantillon, MD, Heart & Vascular Institute
Leslie Cho, MD, Heart & Vascular Institute
Conor Delaney, MD, PhD, Chair, Digestive Disease & Surgery Institute
Pauline Funchain, MD, Taussig Cancer Institute
Steve Gordon, MD, Chair, Infectious Disease
Alberto Montero, MD, Taussig Cancer Institute
Aleksandra Rachitskaya, MD, Cole Eye Institute
Jonathan Schaffer, MD, Orthopaedic & Rheumatologic Institute
Tina Waters, MD, Sleep Disorders Center
Jim Young, MD, Chair, Endocrinology & Metabolism Institute
Keynote: Jennifer Lee, MD, Deputy Under Secretary for Health for Policy & Services, Veterans Affairs
Keynote: Implementing Precision Medicine: Eric Green, MD, PhD, Director, NIH National Human Genome Research Institute
Starting with the launch of the Human Genome Project in 1990, the field of genomics has brought spectacular advances to empower the study of human biology and disease. In recent years, clinical applications of genomics have begun to emerge, ushering in the era of genomic medicine.
There is no question that cancer is a key priority for U.S. companies, research institutes, and government agencies. While collaborative efforts are underway, we often can’t help but wonder whether it will be enough. Experts on this panel will discuss the latest government investments and the policies needed to push cancer to its tipping point.
Moderator: Reed Tuckson, MD, Managing Director, Tuckson Health Connections, LLC
Anna Abram, Deputy Commissioner,, FDA
Brian Bolwell, MD, Chair, Taussig Cancer Institute, Cleveland Clinic
Eric Green MD, PhD, Director, National Human Genome Research Institute, NIH
Jennifer Lee, MD, Deputy Under Secretary for Health for Policy & Services, Veterans Affairs
In 2014, Cleveland Clinic partnered with Vizient to develop a new type of sourcing model based on clinical evidence and led by physicians to facilitate product decision making. This session will identify Cleveland Clinic's journey to developing a physician-led sourcing model and process supported by a supply cost analytics tool to align physicians around clinical and cost priorities.
David Gurd, MD, Head of Pediatric Spinal Deformity Surgery and Medical Director, Supply Chain Management, Cleveland Clinic, and Medical Director, Excelerate
Simrit Sandhu, Executive Director, Supply Chain Management, Cleveland Clinic
Tapped to lead time and time again, Jan Murphy generously shares her story of success as a serving leader at Cleveland Clinic.
Jan Murphy, RN, COO, Regional Hospitals & Family Health Centers, Cleveland Clinic
Known for a culture built on strong core values, Boston Scientific continues to innovate with its product and services as well as in its relationship with the broader healthcare system. Boston Scientific CEO Mike Mahoney joins Dr. Delos Cosgrove for a candid conversation on a range of topics, from the challenges and opportunities facing the device industry to the role of devices in precision medicine, and how the company fosters innovation across the 27,000-employee enterprise.
Mike Mahoney, President & CEO, Boston Scientific
Moderator: Delos Cosgrove, MD, CEO & President, Cleveland Clinic
In a new era of value-based technology, the need to demonstrate outcomes is becoming critical. The medical device industry in particular is showing signs of abandoning its one-size-fits-all mentality in favor of a hyper-precise methodology that accounts for the unique needs of the individual. This panel will discuss how the biggest players in the industry are investing in this new market, and give a glimpse of some novel technologies that are leading this new charge.
Moderator: Wael Barsoum, MD, President, Cleveland Clinic Florida
Gary Guthart, PhD, President & CEO, Intuitive Surgical
Kevin Lobo, Chairman & CEO, Stryker
Rakesh Mehta, Managing Director, J.P. Morgan
Hear from opera singer and double lung transplant recipient.
Charity Tillemann-Dick, an American-born soprano and top-selling classical recording artist
When it comes to the potential to save lives and market opportunities, it turns out the gut is a gold mine. The trillions of bacteria, which make up communities in our body, referred to as the microbiome, are unlocking mysteries at an incredible pace. Experts on this panel will review the latest attempts and strategies to successfully translate the microbiome from the bench to patients and consumers.
Moderator: Wilson Tang, MD Director, Center for Clinical Genomics, Cleveland Clinic
John L. Brooks III, President & Founder, Healthcare Capital, LLC
Jose Carlos Garcia-Garcia, PhD,Principal Scientist, Procter & Gamble
Stanley Hazen, MD, PhD, Chair, Cellular & Molecular Medicine, Lerner Research Institute, Cleveland Clinic
Roger Pomerantz, MD, President & CEO, Seres Therapeutics
Devices that break down barriers were among the winning entries at this past weekend’s third annual Cleveland Medical Hack-a-thon.
Cleveland Clinic's Medical Innovation Summit, slated for Oct. 23 to Oct. 25 in downtown Cleveland, will focus on advancements in genomics and precision medicine.
Genomics and precision medicine will be the focus of Cleveland Clinic Medical Innovation Summit, taking place Monday through Wednesday, at the Huntington Convention Center in downtown Cleveland. Green is a featured speaker at the summit.
The Cleveland Medical Hackathon is Oct. 21-22 at the Global Center for Health Innovation in downtown Cleveland. Think of it as a prelude to the Cleveland Clinic Medical Innovation Summit, which begins Oct. 23 and runs through Oct. 25 at the same location.
This potentially transformative discipline is the subject of the Cleveland Clinic's Medical Innovation Summit, to be held Oct. 23-25 downtown. The summit is set to gather more than 2,000 health care and business leaders, among them Dr. Charis Eng, founder of the Clinic's Genomic Medicine Institute (GMI). Eng is a firm believer in the promise of genomics and precision medicine, having identified four of 10 genes known to be associated with breast cancer and another six connected to Cowden syndrome, a disorder that carries high risk of breast, thyroid and other cancers.
Gene therapy, artificial intelligence and customized implants are among the topics that will be discussed at the annual Cleveland Clinic's Medical Innovation Summit, coming this fall to downtown Cleveland.
Precision Medicine Policy Keynotes
Precision Medicine Policy: Can the Government Cure Cancer?
Precision Squared: Population Management Meets Personalized Medicine
Psychological Safety - A New Safety Metric
Special Performance: Chairty Tillemann-Dick
Intro & Welcome
The State of Healthcare Innovation: A Pharma Perspective
Hype, Hope, and the Bottom Line: Reimbursement Strategies For Genomic Innovation
Genomics, Advanced Imaging, and the Future of Medicine
Breaking the Code: Will Next-Generation Sequencing Bring Genomis to the Mainstream
Zeroing in on Disease: The Latest Tools in risk Stratification and Early Detection